Invesco Nasdaq Biotechnology ETF Rating → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IBBQ Stock Alerts $21.69 -0.18 (-0.82%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy2.57Holdings in IBBQ have an aggregate rating of Moderate Buy based on 631 analyst ratings issued in the past year covering 50 companies (80.6% of the portfolio).IBBQ Aggregate Price Target$26.1320.46% UpsideHigh Prediction$34.39Average Prediction$26.13Low Prediction$18.80Holdings in IBBQ have an aggregate price target of $26.13 and a range of $18.80 to $34.39 covering 50 companies (80.6% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.99%AMGNAmgen$310.15-0.9%5 of 5 stars2.52$305.65 -1.5%21Analyst Forecast8.17%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%20Positive News7.86%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast7.47%GILDGilead Sciences$65.96+2.1%5 of 5 stars2.39$83.69 26.9%18Analyst Revision4.90%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst ForecastInsider SellingNews Coverage4.63%AZNAstraZeneca$77.18-0.6%2 of 5 stars2.57$81.00 4.9%73.38%BIIBBiogen$221.50-0.6%5 of 5 stars2.65$288.46 30.2%26Positive News2.00%ALNYAlnylam Pharmaceuticals$150.47-0.6%4 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision1.98%ILMNIllumina$110.53-0.7%5 of 5 stars2.30$164.65 49.0%20Analyst ForecastShort Interest ↓1.63%BMRNBioMarin Pharmaceutical$81.03-0.8%5 of 5 stars2.63$107.50 32.7%19Short Interest ↑1.48%NBIXNeurocrine Biosciences$136.70-2.1%5 of 5 stars2.74$147.88 8.2%231.47%VTRSViatris$11.16-0.5%1 of 5 stars1.33$11.00 -1.4%3Earnings ReportDividend AnnouncementNews Coverage1.42%SNYSanofi$49.28+1.2%3 of 5 stars2.40$55.00 11.6%5Short Interest ↑News Coverage1.34%RPRXRoyalty Pharma$28.09+0.4%5 of 5 stars3.00$46.75 66.4%4Earnings ReportAnalyst DowngradeNews Coverage1.33%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%141.29%UTHRUnited Therapeutics$264.27-0.7%5 of 5 stars2.90$308.78 16.8%10Insider Selling1.29%MEDPMedpace$390.19-2.3%5 of 5 stars2.80$443.00 13.5%5Insider SellingNews Coverage1.28%INCYIncyte$53.06-0.8%5 of 5 stars2.47$74.93 41.2%17Short Interest ↑1.28%ARGXargenx$374.63-2.1%3 of 5 stars2.71$527.84 40.9%21Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.98%ROIVRoivant Sciences$11.13-1.1%3 of 5 stars2.90$16.90 51.8%10Positive News0.95%BNTXBioNTech$91.67-0.4%2 of 5 stars2.27$118.82 29.6%11Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.81%ASNDAscendis Pharma A/S$133.46+0.2%1 of 5 stars2.88$173.88 30.3%80.76%PCVXVaxcyte$65.19-0.6%1 of 5 stars3.00$78.50 20.4%4Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.72%ITCIIntra-Cellular Therapies$64.96-0.9%5 of 5 stars2.90$90.17 38.8%10Earnings ReportAnalyst ForecastAnalyst Revision0.72%JAZZJazz Pharmaceuticals$109.63-3.1%5 of 5 stars2.85$192.75 75.8%13Insider Selling0.71%BGNEBeiGene$161.13-4.5%3 of 5 stars2.80$251.93 56.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up0.70%CYTKCytokinetics$62.10-3.0%4 of 5 stars2.87$81.60 31.4%15Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage0.70%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑0.68%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑Analyst Revision0.68%RVMDRevolution Medicines$37.25-0.5%4 of 5 stars3.10$41.60 11.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.65%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓0.62%APLSApellis Pharmaceuticals$41.99-1.2%5 of 5 stars2.87$76.67 82.6%15Earnings ReportAnalyst ForecastInsider SellingShort Interest ↑Analyst RevisionNews Coverage0.55%IBRXImmunityBio$8.12+0.7%0 of 5 stars2.00$6.00 -26.1%1Gap Down0.54%HALOHalozyme Therapeutics$43.15-1.6%5 of 5 stars2.83$53.14 23.2%6Analyst Forecast0.52%BBIOBridgeBio Pharma$29.10+1.3%5 of 5 stars2.80$47.82 64.3%10Short Interest ↑0.50%MDGLMadrigal Pharmaceuticals$205.25-0.8%5 of 5 stars2.73$345.09 68.1%11Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.48%CRSPCRISPR Therapeutics$51.17-4.4%3 of 5 stars2.35$73.93 44.5%17Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage0.46%KRYSKrystal Biotech$154.76-2.5%5 of 5 stars3.00$171.00 10.5%9Earnings ReportShort Interest ↑Analyst RevisionNews Coverage0.45%IMVTImmunovant$29.39-1.0%2 of 5 stars3.00$48.00 63.3%17Short Interest ↑0.44%ALPNAlpine Immune Sciences$64.94+0.2%2 of 5 stars2.27$50.33 -22.5%11Short Interest ↓0.42%ALKSAlkermes$24.05-0.9%5 of 5 stars2.50$35.38 47.1%10Positive News0.42%NUVLNuvalent$65.48-3.0%3 of 5 stars2.90$90.78 38.6%10Earnings ReportInsider SellingAnalyst RevisionNews Coverage0.41%IOVAIovance Biotherapeutics$10.97-18.4%5 of 5 stars3.00$24.64 124.7%10Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume0.40%INSMInsmed$25.97-1.6%4 of 5 stars3.00$45.08 73.6%12Earnings ReportAnalyst ForecastOptions VolumeNews Coverage0.38%LEGNLegend Biotech$43.24-5.0%2 of 5 stars2.92$82.64 91.1%12Upcoming EarningsAnalyst ForecastShort Interest ↑News Coverage0.38%AXSMAxsome Therapeutics$72.50-1.6%4 of 5 stars2.92$121.92 68.2%13Analyst ForecastAnalyst RevisionNews Coverage0.37%RAREUltragenyx Pharmaceutical$40.90-0.8%4 of 5 stars2.92$87.85 114.8%120.36%SWTXSpringWorks Therapeutics$40.89-4.8%2 of 5 stars3.00$68.83 68.3%6Analyst Revision0.34%XENEXenon Pharmaceuticals$40.54-4.6%3 of 5 stars3.00$59.11 45.8%9Earnings ReportAnalyst ForecastNews Coverage0.34%CRNXCrinetics Pharmaceuticals$48.00-2.9%4 of 5 stars2.92$58.42 21.7%12Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓News Coverage This page (NASDAQ:IBBQ) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
